DLL1 and neoplasm: Similar to our in vitro studies, treatment of transplanted Dll1+ and Dll1− tumors with doxorubicin revealed that Dll1+ tumors were resistant, whereas Dll1− tumor growth was significantly impaired upon doxorubicin treatment (Fig. 5a–d).